Institutional Investors Adjust Positions in The Allstate Corporation (ALL)

Why This Matters: Institutional investment activity can significantly influence stock prices. Increased holdings often signal confidence in the company's prospects, while decreased holdings may indicate concerns. Allstate's strong earnings and dividend announcements further support investor interest.

Allstate's stock has seen considerable activity from institutional investors. Price T Rowe Associates Inc. MD, Boston Partners, GAMMA Investing LLC, Mackenzie Financial Corp, and Goldman Sachs Group Inc. have all increased their positions. These changes reflect a broader sentiment among institutional investors. Allstate (NYSE:ALL - Get Free Report) has a market capitalization of $51.72 billion, a price-to-earnings ratio of 9.23, and a beta of 0.37. The company's strong earnings report, with an EPS of $5.94, surpassed analysts' expectations. Revenue for the quarter was up 5.8% year-over-year. The company also declared a quarterly dividend of $1.00 per share, payable on October 1st, with a record date of August 29th. Several analysts have updated their ratings on Allstate, with UBS Group increasing their price objective to $235.00 and Wall Street Zen upgrading the stock to a "buy" rating.

Allstate reported an EPS of $5.94 for the most recent quarter.

Allstate's current dividend yield is 2.0%.

The consensus rating for Allstate stock is "Moderate Buy".

Do you think Allstate is a good investment? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!